The influence of coincidental vascular pathology on symptomatology and course of Alzheimer’s disease

  • F. Pasquier
  • D. Leys
  • P. Scheltens
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 54)


The aim of this review is to determine the influence of coincidental cerebrovascular pathology on the symptomatology and course of Alzheimer’s disease (AD). The link between stroke and AD is probably higher than expected by chance for the following reasons: (i) both pathologies share genetic risk factors such as the ε4 allele of the apolipoprotein E gene; (ii) AD patients have changes in the brain vessels that may lead to either ischemic or hemorrhagic stroke or white matter changes or both; (iii) there is evidence of an increased risk of stroke in AD patients; (iv) there is evidence of a frequent association of AD and stroke at autopsy. Because of the summation of the various types of lesions, stroke lesions may lead to an increase progression of cognitive decline in AD patients. Recognition of a vascular component in a dementia syndrome is therefore useful for the management of AD patients. Whether an optimal management of risk factors for stroke may delay the clinical expression of dementia in patients with preclinical Alzheimer pathology should be evaluated.


Stroke Patient Vascular Dementia White Matter Lesion Cerebral Amyloid Angiopathy White Matter Hyperintensities 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aharon-Peretz J, Cummings JL, Hill MA (1988) Vascular dementia and dementia of the Alzheimer type. Cognition, ventricular size and leuko-araiosis. Arch Neurol 45: 719–721PubMedCrossRefGoogle Scholar
  2. Albert MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders AM, Roses AD (1995) ApoE genotype and survival from intracerebral haemorrhage. Lancet 346: 575CrossRefGoogle Scholar
  3. Alperovitch A, Mas JL, Doyon B, Myquel P (1986) Mortality from stroke in France 1968–1982. Neuroepidemiology 5: 80–87PubMedCrossRefGoogle Scholar
  4. Blots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE (1996) Common carotid intima media thickness predicts stroke in the Rotterdam study. J Neurol 243: 6Google Scholar
  5. Bogucki A, Papierz W, Szymanska R, Staniaszczyk R (1988) Cerebral amyloid angiopathy with attenuation of the white matter on CT-scans: subcortical arteriosclerotic encephalopathy (Binswanger) in a normotensive patient. J Neurol 235: 435–437PubMedCrossRefGoogle Scholar
  6. Boone KB, Miller BL, Mehringer CM, Hill-Gutierrez E, Goldberg MA, Berman NG (1992) Neuropsychological correlates of white-matter lesions in healty elderly subject. A threshold effect. Arch Neurol 49: 549–554PubMedCrossRefGoogle Scholar
  7. Breteler MMB, Van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JHW, van Harskamp F, Tanghe HLJ, de Jong PRVM, van Gijn J, Hofman A (1994a) Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study. Neurology 44: 1246–1252PubMedCrossRefGoogle Scholar
  8. Breteler MMB, Claus JJ, Grobbee DE, Hofman A (1994b) Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study. Br Med J 308: 1604–1608CrossRefGoogle Scholar
  9. Brun A, Englund E (1986) A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19: 253–262PubMedCrossRefGoogle Scholar
  10. Cadelo M, Inzitari D, Pracucci G, Mascalchi M (1991) Predictors of leukoaraiosis in elderly neurological patients. Cerebrovasc Dis 1: 345–351CrossRefGoogle Scholar
  11. DeCarli C, Murphy DGM, Tranh M, Grady CL, Haxby JV, Gilette JA, Salerno JA, Gonzales-Aviles A, Horwitz B, Rapoport SI, Schapiro MB (1995) The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 45: 2077–2084PubMedCrossRefGoogle Scholar
  12. Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A (1996) Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, part XV. Neurology 46: 1592–1596PubMedCrossRefGoogle Scholar
  13. Erkinjuntti T, Hachinski VC (1993) Rethinking vascular dementia. Cerebrovasc Dis 3: 3–23CrossRefGoogle Scholar
  14. Erkinjuntti T, Ketonen L, Sulkava R, Sipponen J, Vuorialho M, Iivanainen M (1987) Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer’s disease? J Neurol Neurosurg Psychiatry 50: 37–42PubMedCrossRefGoogle Scholar
  15. Erkinjuntti T, Gao F, Lee DH, Eliasziw M, Merskey H, Hachinski VC (1994) Lack of difference in brain hyperintensities between patients with early Alzheimer’s disease and control subjects. Arch Neurol 51: 260–268PubMedCrossRefGoogle Scholar
  16. Ferrucci L, Guralnik JM, Salive ME, Pahor M, Corti MC, Baroni A, Havlik RJ (1996) Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc 44: 237–241PubMedGoogle Scholar
  17. Fisher MC (1969) The arterial lesions underlying lacunes. Acta Neuropathol (Berl) 12:1–15CrossRefGoogle Scholar
  18. Frisoni G, Geroldi C, Blanquetti A, Trabucchi M, Govoni S, Franceschini G, Calabresi L (1994) Apolipoprotein e4 allele frequency in vascular dementia and Alzheimer’s disease (letter). Stroke 25: 1703PubMedCrossRefGoogle Scholar
  19. Fukuda H, Kobayaski S, Okada K, Tsunematsu T (1990) Frontal white matter lesions and dementia in lacunar infarction. Stroke 21: 1143–1149PubMedCrossRefGoogle Scholar
  20. Gerdes LU (1994) Apolipoprotein E genotypes and cardiovascular disease: a quantitative overview of 42 studies. Genet Epidemiol 11: 294Google Scholar
  21. Haan J, Maat-Schieman MLC, Roos RAC (1994a) Clinical effects of cerebral amyloid angiopathy. Dementia 5: 210–213PubMedGoogle Scholar
  22. Haan J, Maat-Schieman MLC, Van Duinen SG, Jensson O, Thorsteinsson L, Roos RAC (1994b) Co-localization of βA4 and cystatin C in cortical blood vessels in Dutch, but not in Icelandic hereditary cerebral hemorrhage with amyloidosis. Acta Neurol Scand 89: 367–371PubMedCrossRefGoogle Scholar
  23. Hachinski VC, Potter P, Merskey H (1987) Leuko-Araiosis. Arch Neurol 44: 21–23PubMedCrossRefGoogle Scholar
  24. Hénon H, Durieu I, Lucas C, Godefroy O, Pasquier F, Leys D (1996) Prevalence of preexisting dementia in consecutive stroke patients. Neurology 47: 852–853PubMedCrossRefGoogle Scholar
  25. Hénon H, Godefroy O, Lucas Ch, Pruvo JP, Leys D (1996) Risk factors for leuko-araiosis in stroke patients. Acta Neurol Scand 94: 137–144PubMedCrossRefGoogle Scholar
  26. Hijdra A, Verbeeten B Jr (1991) Leuko-araiosis and ventricular enlargement in patients with ischemic stroke. Stroke 22: 447–450PubMedCrossRefGoogle Scholar
  27. Hijdra A, Verbeeten B Jr, Verhulst JAPM (1990) Relation of Leukoaraiosis to lesion type in stroke patients. Stroke 21: 890–894PubMedCrossRefGoogle Scholar
  28. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, Van Harskamp F, Van Duijn CN, Van Broeckhoven C, Grobbee DE (1997) Atherosclerosis, apolopoprotein E and prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet 349: 151–154PubMedCrossRefGoogle Scholar
  29. Ince PG, McArthur FK, Bjertness E, Torvik A, Candy JM, Edwardson JA (1995) Neuropathological diagnoses in elderly patients in Oslo: Alzheimer’s disease, Lewy body disease, vascular lesions. Dementia 6: 162–168PubMedGoogle Scholar
  30. Inzitari D, Diaz F, Fox A, Hachinski VC, Steingart A, Lau C, Donald A, Wade J, Mulic H, Merskey H (1987) Vascular risk factors and Leuko-Araiosis. Arch Neurol 44: 42–47PubMedCrossRefGoogle Scholar
  31. Inzitari D, Giordano GP, Ancona AL, Pracucci G, Mascalchi M, Amaducci L (1990) Leuko-araiosis, intracerebral hemorrhage and arterial hypertension. Stroke 21:1419–1423PubMedCrossRefGoogle Scholar
  32. Ishii N, Nishihara Y, Imamura T (1986) Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology 36: 340–345PubMedCrossRefGoogle Scholar
  33. Jellinger K, Danielczyk W, Fischer P, Gabriel E (1990) Clinico-pathological analysis of dementia disorders in the elderly. J Neurol Sci 95: 239–258PubMedCrossRefGoogle Scholar
  34. Kinkel WR, Jacobs L, Polachini I, Bates V, Heffner RR Jr (1995) Subcortical arteriosclerotic encephalopathy (Binswanger’s disease). Computer tomographic nuclear magnetic resonance and clinical correlations. Arch Neurol 42: 951–959CrossRefGoogle Scholar
  35. Kokmen E, Whisnant JP, O’Fallon WN, Chu CP, Beard CM (1996) Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960–1984). Neurology 46: 154–159PubMedCrossRefGoogle Scholar
  36. Leys D, Bogousslavsky J (1994) Mechanisms of vascular dementia. In: Leys D, Scheltens P (eds) Vascular dementia. ICG Publications, Dordrecht, pp 121–132Google Scholar
  37. Leys D, Pruvo JP, Parent M, Vermersch P, Soetaert G, Steinling M, Delacourte A, Defossez A, Rapoport A, Clarisse J, Petit H (1991) Could Wallerian degeneration contribute to “Leuko-Araïosis” in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry 54: 46–50.PubMedCrossRefGoogle Scholar
  38. Leys D, Pruvo JP, Scheltens Ph, Rondepierre Ph, Godefroy O, Leclerc X, De Reuck J (1992) Leuko-araiosis. Relationship with the types of focal lesions occurring in acute cerebrovascular disorders. Cerebrovasc Disord 2: 169–176CrossRefGoogle Scholar
  39. Leys D, Hénon H, Pasquier F, Durieu I, Pruvo JP (1997) Medial temporal lobe atrophy in stroke patients: relationship with pre-stroke dementia. Neurology 48: A206Google Scholar
  40. Liu CK, Miller BL, Cummings JL, Mehringer CM, Goldberg MA, Howng SL, Benson DF (1992) A quantitative MRI study of vascular dementia. Neurology 42: 138–143PubMedCrossRefGoogle Scholar
  41. Loeb C, Gandolfo C, Croce R, Conti M (1992) Dementia associated with lacunar infarction. Stroke 23: 1225–1229PubMedCrossRefGoogle Scholar
  42. Lucas C, Parent M, Delandsheer E, Delacourte A, Fournier Y, Defossez A, Leys D (1992) Hémorragies cér‘brales multiples et angiopathie amyloide de la substance blanche dans un cas de maladie d’Alzheimer. Rev Neurol (Paris) 148: 218–220Google Scholar
  43. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 34: 939–944PubMedCrossRefGoogle Scholar
  44. Pasquier F, Leys D (1997) Why are stroke patients prone to develop dementia? J Neurol 244: 135–142PubMedCrossRefGoogle Scholar
  45. Pasquier F, Lebert F, Petit H (1994) Pseudo progressive dementia and “strategic” infarcts. In: Leys D, Scheltens P (eds) Vascular dementia. ICG Publications, Dordrecht, pp 47–54Google Scholar
  46. Pasquier F, Lebert F, Petit H (1995) Dementia, apathy and thalamic infarcts. Neuropsychiat Neuropsychol Behav Neurol 8: 208–214Google Scholar
  47. Rezek DL, Morris JC, Fulling KH, Gado MH (1987) Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal ageing. Neurology 37: 1365–1368PubMedCrossRefGoogle Scholar
  48. Rocca WA, Bonaiuto S, Lippi A, Luciani P, Turtù F, Cavarzeran F, Amaducci L (1990) Prevalence of clinically diagnosed Alzheimer’s disease and other dementing disorders: a door-to-door survey in Appignano, Macerata Province, Italy. Neurology 40: 626–631PubMedCrossRefGoogle Scholar
  49. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O’Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P (1993) Vascular dementia: diagnostic criteria for research studies. Neurology 43: 250–260PubMedCrossRefGoogle Scholar
  50. Rubinsztein DC (1995) Apolipoprotein E: a review of its roles in lipoprotein metabolism, neuronal growth and repair and as a risk factor for Alzheimer’s disease. Psychol Med 25: 223–229PubMedCrossRefGoogle Scholar
  51. Saunders AM, Roses AD (1993) Apolipoprotein E allele frequency, ischemic cerebrovascular disease, and Alzheimer’s disease (letter). Stroke 24: 1416PubMedCrossRefGoogle Scholar
  52. Scheltens Ph, Barkhof F, Valk J, Algra PR, Gerritsen Van Der Hoop R, Nauta J, Wolters E Ch (1992) White matter lesions on magnetic resonance imaging in Alzheimer’s disease: evidence for heterogeneity. Brain 115: 735–743PubMedCrossRefGoogle Scholar
  53. Schmidt R (1992) Comparison of magnetic resonance imaging in Alzheimer’s disease, vascular dementia and normal aging. Eur Neurol 32: 164–169PubMedCrossRefGoogle Scholar
  54. Schmidt R, Fazekas F, Offenbacher H, Lytwyn H, Blematl B, Niederkorn K, Horner S, Payer F, Freidl W (1991) Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Arch Neurol 48: 417–420PubMedCrossRefGoogle Scholar
  55. Schmidt R, Fazekas F, Kleinert G, Offenbacher H, Gindl K, Payer F, Friedl W, Niderkorn K, Lechner H (1992) Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Arch Neurol 49: 825–827PubMedCrossRefGoogle Scholar
  56. Schmidt R, Fazekas F, Offenbacher H, Dusek T, Zach E, Reinhart B, Grieshofer P, Freidl W, Eber B, Schumacher M, Koch M, Lechner H (1993) Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology 43: 2490–2494PubMedCrossRefGoogle Scholar
  57. Shimano H, Ishibashi S, Murase T (1989) Plasma apolipoproteins in patients with multi-infarct dementia. Atherosclerosis 79: 257–260PubMedCrossRefGoogle Scholar
  58. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Odén A, Svanborg A (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347: 1141–1145PubMedCrossRefGoogle Scholar
  59. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The nun study. JAMA 277: 813–817PubMedCrossRefGoogle Scholar
  60. Steingart A, Hachinski VC, Lau C, Fox AJ, Fox H, Lee D, Inzitari D, Merskey H (1987) Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (Leuko-Araiosis). Arch Neurol 44: 36–39PubMedCrossRefGoogle Scholar
  61. Stephenson DT, Rash K, Clemens JA (1992) Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res 593: 128–135PubMedCrossRefGoogle Scholar
  62. Tatemichi TK, Foulkes MA, Mohr JP, Hewitt JR, Hier DB, Price TR, Wolf PA (1990) Dementia in stroke survivors in the stroke data bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke 21: 858–866PubMedCrossRefGoogle Scholar
  63. Tatemichi TK, Desmond DW, Mayeux R Paik M, Stern Y, Sano M, Remien RH, Williams JBW, Mohr JP, Hauser WA, Figueroa M (1992) Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 42: 1185–1193PubMedCrossRefGoogle Scholar
  64. Tatemichi TK, Paik M, Bagiella E, Desmond DW, Stern Y, Sano M, Hauser WA, Mayeux R (1994) Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 44: 1885–1891PubMedCrossRefGoogle Scholar
  65. Terayama, Meyer JS, Kawamura J, Weathers S, Mortel KF (1992) Patterns of cerebral hypoperfusion compared among demented and nondemented patients with stroke. Stroke 23: 686–692PubMedCrossRefGoogle Scholar
  66. van Swieten JC, Geyskes GG, Derix MMA, Peeck BM, Ramos LMP, van Latum JC, van Gijn J (1991) Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 30: 825–830PubMedCrossRefGoogle Scholar
  67. Victoroff J, Mack WJ, Lyness SC, Chui HC (1995) Multicenter clinicopathological correlation in dementia. Am J Psychiatry 152: 1476–1484PubMedGoogle Scholar
  68. Vinters HV (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18: 311–324PubMedCrossRefGoogle Scholar
  69. Yamada M, Tsukagoshi H, Otomo E, Hayakawa M (1987) Cerebral amyloid angiopathy in the aged. J Neurol 234: 371–376PubMedCrossRefGoogle Scholar
  70. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R (1993) White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 50: 818–824PubMedCrossRefGoogle Scholar
  71. Yoshimura M, Yamanouchi H, Kuzuhara S, Mori H, Sugiura S, Mizutani T, Shimada H, Tomonaga M, Toyokura Y (1992) Dementia in cerebral amyloid angiopathy: a clinicopathological study. J Neurol 239: 441–450PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1998

Authors and Affiliations

  • F. Pasquier
    • 1
  • D. Leys
    • 2
  • P. Scheltens
    • 3
  1. 1.Memory, Department of NeurologyUniversity of LilleFrance
  2. 2.Stroke Units, Department of NeurologyUniversity of LilleFrance
  3. 3.Department of NeurologyAcademisch Ziekenhuis Vrije UniversiteitAmsterdamThe Netherlands

Personalised recommendations